Angela Vincent - Related publications

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Area:
neuroimmunology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
16 most relevant papers in past 60 days:
Year Citation  Score
2021 Islam MN, Dipi RM, Mostafa SN, Datta A. Progression of Disease in COVID-19 Patients Evaluated by Chest CT Imgaing and Correlated with Clinical Parameters. Mymensingh Medical Journal : Mmj. 30: 182-188. PMID 33397872   
2021 Liu HQ, Yuan B, An YW, Chen KJ, Hu Q, Hu XP, Zhao J, Dong Y, Chen YX, Li WX, Sun CQ, Wang JC, Wang C, Song S. Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period. International Journal of Medical Sciences. 18: 347-355. PMID 33390803 DOI: 10.7150/ijms.50873   
2021 Lin L, Zhong C, Rao S, Lin H, Huang R, Chen F. Clinical characteristics of 78 cases of patients infected with coronavirus disease 2019 in Wuhan, China. Experimental and Therapeutic Medicine. 21: 7. PMID 33235616 DOI: 10.3892/etm.2020.9439   
2021 Pandya A, Burgen E, Chen GJ, Hobson J, Nguyen M, Pirzad A, Hayat Khan S. Comparison of management options for specific antibody deficiency. Allergy and Asthma Proceedings. 42: 87-92. PMID 33404392 DOI: 10.2500/aap.2021.42.200086   
2021 Mondal E, Khan MM, Hossain MI, Moshwan MM, Saha R, Das SN, Moniruzzaman M. The Pattern of Lipid Profile in Patients with Chronic Kidney Disease. Mymensingh Medical Journal : Mmj. 30: 48-55. PMID 33397850   
2021 Eskelund CW, Dimopoulos K, Kolstad A, Glimelius I, Räty R, Gjerdrum LMR, Sonnevi K, Josefsson P, Nilsson-Ehle H, Bentzen HHN, Fagerli UM, Kuittinen O, Haaber J, Niemann CU, Pedersen LB, et al. Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3. Hemasphere. 5: e510. PMID 33364550 DOI: 10.1097/HS9.0000000000000510   
2021 Fuentes P, Toribio ML, González-García S. Human T-ALL Xenografts. Methods in Molecular Biology (Clifton, N.J.). 2185: 215-239. PMID 33165851 DOI: 10.1007/978-1-0716-0810-4_13   
2021 Sugimoto T, Fujimoto D, Sato Y, Tamiya M, Yokoi T, Tamiya A, Iwasawa S, Hata A, Uchida J, Fukuda Y, Hara S, Kanazu M, Hirano K, Kokubo M, Yamamoto N. Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study. Investigational New Drugs. PMID 33405089 DOI: 10.1007/s10637-020-01060-8   
2021 You H, Dang G, Lu B, Zhang S, Li C, Wang L, Hu Y, Chen H, Zhang J, He W. Serum Sp17 Autoantibody Serves as a Potential Specific Biomarker in Patients with SAPHO Syndrome. Journal of Clinical Immunology. PMID 33392854 DOI: 10.1007/s10875-020-00937-w   
2021 Naidus E, Bouquet J, Oh DY, Looney TJ, Yang H, Fong L, Standifer NE, Zhang L. Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients. Cancer Immunology, Immunotherapy : Cii. PMID 33420629 DOI: 10.1007/s00262-020-02833-z   
2021 Chen TW, Pang A, Puhaindran ME, Maw MM, Loong HH, Sriuranpong V, Chang CC, Mingmalairak S, Hirose T, Endo M, Kawai A, Farid M, Tan SH, Goh WL, Quek R, et al. The Treatment Landscape of Advanced Angiosarcoma in Asia-A multi-National Collaboration From The asian Sarcoma Consortium. Cancer Science. PMID 33393133 DOI: 10.1111/cas.14793   
2021 Hu S, Chen N, Lu K, Zhen C, Sui X, Fang X, Li Y, Luo Y, Zhou X, Wang X. The prognostic roles of hepatitis B virus antibody in diffuse large B-cell lymphoma patients. Leukemia & Lymphoma. 1-15. PMID 33399486 DOI: 10.1080/10428194.2020.1867726   
2021 Fundora Ramos MI, Maden LB, Casanova FO, Cruz FH, Reyes CS, Gato AH, Lyncon IB, González EV, Morales KP, Lence JJ, Sanz E. Oncoxin-Viusid may improve quality of life and survival in patients with hormone-refractory prostate cancer undergoing onco-specific treatments. Molecular and Clinical Oncology. 14: 5. PMID 33235733 DOI: 10.3892/mco.2020.2167   
2021 Kalicińska E, Szymczak D, Andrasiak I, Bogucka-Fedorczuk A, Zińczuk A, Szymański W, Biernat M, Rymko M, Semeńczuk G, Jabłonowska P, Rybka J, Simon K, Wróbel T. Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study. Translational Oncology. 14: 100943. PMID 33204385 DOI: 10.1016/j.tranon.2020.100943   
2021 Tajima H, Makino I, Gabata R, Okazaki M, Ohbatake Y, Shimbashi H, Nakanuma S, Saitoh H, Shimada M, Yamaguchi T, Okamoto K, Moriyama H, Kinoshita J, Nakamura K, Miyashita T, et al. A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus -paclitaxel for resectable pancreatic cancer. Molecular and Clinical Oncology. 14: 26. PMID 33414907 DOI: 10.3892/mco.2020.2188   
2021 Zheng W, Jiang F, Shan J, Wang Y, Jia Y, Guo Q, Lou J, Zhao Y. Levels of serum IgG subclasses in patients with liver disease: A retrospective study. Experimental and Therapeutic Medicine. 21: 45. PMID 33273974 DOI: 10.3892/etm.2020.9476